Literature DB >> 12088962

An investigation of monoamine receptors involved in antinociceptive effects of antidepressants.

Fumiko Yokogawa1, Yuji Kiuchi, Yuji Ishikawa, Naoki Otsuka, Yutaka Masuda, Katsuji Oguchi, Akiyoshi Hosoyamada.   

Abstract

UNLABELLED: We attempted to determine which monoamine receptor subtypes are predominantly involved in antidepressant-induced antinociception. Antinociceptive effects were evaluated by using formalin tests with rats. Antidepressants acting as potent inhibitors of norepinephrine reuptake (nisoxetine, nortriptyline, and maprotiline) or inhibiting reuptake of both norepinephrine and serotonin (5-HT) (imipramine and milnacipran) induced dose-dependent antinociception. Simultaneous intraperitoneal administration of antidepressants and either prazosin (alpha(1) antagonist) or ketanserin (5-HT(2) antagonist) significantly antagonized antinociceptive effects. Fluvoxamine (selective serotonin reuptake inhibitor) induced antinociception less potently than other antidepressants and was significantly antagonized by ketanserin, but not prazosin. Ondansetron (5-HT(3) antagonist) significantly antagonized antinociception by 10 mg/kg of imipramine. In contrast, SDZ-205,557 (5-HT(4) antagonist) markedly enhanced antinociception by small-dose (2.5 mg/kg) imipramine. Imipramine-induced antinociception was significantly antagonized by intracerebroventricular administration of prazosin or ketanserin, but not by yohimbine (alpha(2) antagonist) or ondansetron, and was significantly enhanced by intracerebroventricularly administered SDZ-205,557. These findings suggest that alpha(1) adrenoceptors and 5-HT(2) receptors in the brain are involved in antidepressant-induced antinociception. In addition, the results suggested functional interactions between noradrenergic and serotonergic neurons as mechanisms for antidepressant-induced antinociception. IMPLICATIONS: Formalin tests of rats treated with antidepressants and antagonists of monoamine receptors indicate that alpha(1) adrenoceptors, serotonin (5-HT)(2) receptors, and 5-HT(3) receptors are involved in antidepressant-induced antinociception, suggesting functional interactions between noradrenergic and serotonergic neurons as mechanisms of antidepressant-induced antinociception.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12088962     DOI: 10.1097/00000539-200207000-00029

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  25 in total

1.  Disrupting 5-HT(2A) receptor/PDZ protein interactions reduces hyperalgesia and enhances SSRI efficacy in neuropathic pain.

Authors:  Xavier Pichon; Anne S Wattiez; Carine Becamel; Ingrid Ehrlich; Joel Bockaert; Alain Eschalier; Philippe Marin; Christine Courteix
Journal:  Mol Ther       Date:  2010-06-08       Impact factor: 11.454

2.  The effect of serotonin-noradrenaline reuptake inhibitor duloxetine on the intervertebral disk-related radiculopathy in rats.

Authors:  Junichi Handa; Miho Sekiguchi; Olga Krupkova; Shin-Ichi Konno
Journal:  Eur Spine J       Date:  2015-09-22       Impact factor: 3.134

3.  ST36 laser acupuncture reduces pain-related behavior in rats: involvement of the opioidergic and serotonergic systems.

Authors:  Vanessa Erthal; Morgana Duarte da Silva; Francisco J Cidral-Filho; Adair Roberto Soares Santos; Percy Nohama
Journal:  Lasers Med Sci       Date:  2013-01-05       Impact factor: 3.161

Review 4.  The impact of anxiety and mood disorders on physical disease: the worried not-so-well.

Authors:  Richard M Sobel; Dimitri Markov
Journal:  Curr Psychiatry Rep       Date:  2005-06       Impact factor: 5.285

5.  Milnacipran: a selective serotonin and norepinephrine dual reuptake inhibitor for the management of fibromyalgia.

Authors:  Robert H Palmer; Antonia Periclou; Pradeep Banerjee
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-08       Impact factor: 5.346

Review 6.  Fibromyalgia comorbid with anxiety disorders and depression: combined medical and psychological treatment.

Authors:  Marcio Bernik; Thiago P A Sampaio; Lucas Gandarela
Journal:  Curr Pain Headache Rep       Date:  2013-09

7.  Design, synthesis, and biological evaluation of a series of bifunctional ligands of opioids/SSRIs.

Authors:  Munawar A Munawar; Yeon Sun Lee; David Rankin; Jawaria Munir; Josephine Lai; Misbahul A Khan; Victor J Hruby
Journal:  Bioorg Med Chem       Date:  2015-02-03       Impact factor: 3.641

8.  Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise.

Authors:  David M Marks; Manan J Shah; Ashwin A Patkar; Prakash S Masand; Geun-Young Park; Chi-Un Pae
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

9.  Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats.

Authors:  Marisa B Rosenberg; F Ivy Carroll; S Stevens Negus
Journal:  J Pain       Date:  2013-01-16       Impact factor: 5.820

10.  Effect of the antidepressant nefazodone on the density of cells expressing mu-opioid receptors in discrete brain areas processing sensory and affective dimensions of pain.

Authors:  Antonio Ortega-Alvaro; Ignacio Acebes; Gonzalo Saracíbar; Enrique Echevarría; Luis Casis; Juan Antonio Micó
Journal:  Psychopharmacology (Berl)       Date:  2004-04-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.